Literature DB >> 32627260

Associations between systemic inflammation and somatic depressive symptoms: Findings from the Moli-sani study.

Alessandro Gialluisi1, Augusto Di Castelnuovo2, Francesca Bracone1, Amalia De Curtis1, Chiara Cerletti1, Maria Benedetta Donati1, Giovanni de Gaetano1, Licia Iacoviello1,3.   

Abstract

BACKGROUND: The link between systemic inflammation and depression has been deeply investigated, but relatively few studies explored symptom-specific associations, mostly focusing on common inflammatory biomarkers like C-reactive protein (CRP) levels.
METHODS: We investigated associations of low-grade inflammation with depressive symptoms assessed through a reduced version of Patient Health Questionnaire 9 (PHQ-9) in a large population-based cohort of adult Italians (N = 13 301). We built logistic regressions between each depressive symptom and composite index of systemic inflammation based on four circulating biomarkers, namely CRP, Plt, WBC, and GLR (INFLA)-score, a composite blood-based inflammation index, and with its component biomarkers, namely CRP, platelets count (Plt), white blood cells count (WBC), and granulocyte-to-lymphocyte ratio (GLR).
RESULTS: We observed a strong association of the altered appetite/eating symptom with standardized INFLA-score (OR [95% CI] = 1.19 [1.12-1.26]; corrected p = 3.0 × 10-7 ), CRP (1.28 [1.20-1.36]; p = 1.9 × 10-13 ), and WBC (1.13 [1.06-1.20]; p = 2.3 × 10-3 ), and of tiredness/low energy with GLR (1.11 [1.05-1.17]; p = 9.4 × 10-3 ). These associations remained stable within nondepressed participants (PHQ-9 < 10), and after adjustment for the use of antidepressants, main chronic conditions, and lifestyle factors; while they were notably attenuated within depressed participants (PHQ-9 ≥ 10) and-for altered appetite only-by adjustment for obesity.
CONCLUSIONS: This study provides a robust replication of the association previously reported between CRP and altered appetite in a large US population cohort, and supports a link between systemic inflammation, altered appetite, and tiredness. Moreover, it extends this evidence to inflammatory markers other than CRP and suggests new targets for the treatment of atypical depression.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  C-reactive protein; appetite; atypical depression; depressive symptoms; granulocyte-to-lymphocyte ratio; systemic inflammation; tiredness; white blood cells count

Year:  2020        PMID: 32627260     DOI: 10.1002/da.23070

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  4 in total

1.  Circulating Inflammation Markers Partly Explain the Link Between the Dietary Inflammatory Index and Depressive Symptoms.

Authors:  Alessandro Gialluisi; Federica Santonastaso; Marialaura Bonaccio; Francesca Bracone; Nitin Shivappa; James R Hebert; Chiara Cerletti; Maria Benedetta Donati; Giovanni de Gaetano; Licia Iacoviello
Journal:  J Inflamm Res       Date:  2021-09-28

2.  Developing symptom clusters: linking inflammatory biomarkers to depressive symptom profiles.

Authors:  Sabina I Franklyn; Jayme Stewart; Cecile Beaurepaire; Emily Thaw; Robyn J McQuaid
Journal:  Transl Psychiatry       Date:  2022-03-31       Impact factor: 7.989

3.  Identifying the Subtypes of Major Depressive Disorder Based on Somatic Symptoms: A Longitudinal Study Using Latent Profile Analysis.

Authors:  Xiaohui Wu; Yuncheng Zhu; Zhiguo Wu; Jia Huang; Lan Cao; Yun Wang; Yousong Su; Hongmei Liu; Maosheng Fang; Zhijian Yao; Zuowei Wang; Fan Wang; Yong Wang; Daihui Peng; Jun Chen; Yiru Fang
Journal:  Front Psychiatry       Date:  2022-07-12       Impact factor: 5.435

4.  Associations of High-Sensitivity C-Reactive Protein and Interleukin-6 with Depression in a Sample of Italian Adolescents During COVID-19 Pandemic.

Authors:  Maria Serra; Anna Presicci; Luigi Quaranta; Mariaclara Achille; Elvita Caputo; Silvia Medicamento; Francesco Margari; Federica Croce; Lucia Margari
Journal:  Neuropsychiatr Dis Treat       Date:  2022-06-29       Impact factor: 2.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.